GHK-Cu grafted polypeptide microspheres boost osteogenesis and angiogenesis for bone defect repair
Background
Repairing irregular bone defects remains a significant challenge in orthopedic surgery, often limited by the poor integration and insufficient bioactivity of conventional scaffolds. Current approaches struggle to simultaneously promote both osteogenesis (bone formation) and angiogenesis (blood vessel formation), which are critical for effective bone regeneration. Biomimetic scaffolds that mimic the extracellular matrix (ECM) and possess dual osteoinductive and pro-angiogenic properties are highly sought after. The copper peptide GHK-Cu is recognized for its regenerative potential, making it an attractive candidate for functionalizing such biomaterials.
Study Design
Researchers fabricated asymmetric open-hollow nanofibrous microspheres (HNMs) from poly(γ-benzyl-L-glutamate) (PBLG) using emulsion and thermally induced phase separation. Subsequently, GHK-Cu was covalently grafted onto these microspheres to create PBLG-GCu HNMs. The optimized microspheres had an average diameter of 372 ± 102 μm and an opening size of 219 ± 53 μm, with internal nanofiber diameters of 417 ± 78 nm. They assessed cytocompatibility using Live/Dead staining and CCK-8 assays. Osteogenic differentiation of bone marrow mesenchymal stem cells (BMSCs) was evaluated by mineralization and qPCR for gene expression, while angiogenic potential was measured via a tube formation assay.
Results
The PBLG-GCu HNMs demonstrated excellent cytocompatibility, confirming their safety for cellular interaction. Compared to non-functionalized PBLG HNMs, the GHK-Cu grafted microspheres significantly enhanced BMSC mineralization. Furthermore, they robustly upregulated key osteogenic gene expression: Runx2 expression increased by 1.61-fold, OPN (osteopontin) by 3.53-fold, and OCN (osteocalcin) by 2.29-fold.
The most significant finding was the 3.53-fold increase in
OPNexpression, a critical marker for bone matrix maturation, indicating potent osteoinductive capabilities. Beyond osteogenesis, thetube formation assayconfirmed that PBLG-GCu HNMs provided robust angiogenic stimulation, crucial for vascularizing new bone tissue. These results highlight the successful integration of hierarchical structural biomimicry with dual bioactivity.
Key Findings
- PBLG-GCu HNMs exhibited excellent cytocompatibility with BMSCs.
- GHK-Cu grafting enhanced BMSC mineralization compared to non-functionalized microspheres.
- Osteogenic gene
Runx2expression increased by 1.61-fold with PBLG-GCu HNMs. - Osteogenic gene
OPNexpression increased by 3.53-fold with PBLG-GCu HNMs. - PBLG-GCu HNMs significantly stimulated angiogenesis in a tube formation assay.
Why It Matters
This research introduces a promising injectable scaffold that could revolutionize the treatment of irregular bone defects. By combining a biomimetic nanofibrous structure with the regenerative properties of GHK-Cu, this system offers a dual approach to bone repair, simultaneously promoting bone formation and vascularization. The development of injectable, osteoinductive, and pro-angiogenic scaffolds like PBLG-GCu HNMs represents a significant step towards more effective and less invasive bone regeneration strategies. For biohackers and clinicians, this points to future protocols where GHK-Cu could be delivered precisely within a sophisticated biomaterial matrix, potentially accelerating healing and improving outcomes in complex fractures or non-union cases. While currently in vitro, this work lays a strong foundation for future in vivo studies and eventual clinical translation.
ghk-cu
bone-regeneration
osteogenesis
angiogenesis
biomaterials
injectable-scaffold